shouldiuse.io

Categories

VERDICT

Should I use Brightside Health?

Online psychiatry and therapy for depression and anxiety - brightside.com

Depends. Reasonable choice if you want medication-first care for depression or anxiety and have insurance, HSA/FSA, or Medicare/Medicaid. Skip it if you want weekly talk therapy or need fully transparent cash pricing.

Confidence

Medium. Based on ~18 public sources; several unrelated 'Brightside' companies (insurer, cybersecurity, finance) were excluded from analysis.

Ratings

  • Value for money
  • Ease of useNo usable evidence in sources
  • Feature depth
  • Support quality
  • Security posture

Pricing

Not disclosed

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed

Best for

  • Medication-first depression and anxiety care
  • Insured, Medicare, or Medicaid patients
  • HSA/FSA payers
  • Persistent depressive disorder treatment

Not for

  • Guess: anyone wanting weekly in-person talk therapy
  • Guess: crisis or emergency mental-health needs
  • Uninsured buyers needing transparent flat pricing
  • Employers seeking benefits platforms — that is a different Brightside

Gotchas - check before you buy

high

Verify your copay each visit; users report wrong charges.

medium

Confirm total cash price upfront; reviewers flag pricing surprises.

medium

HSA/FSA eligibility can differ between therapy and psychiatry — verify first.

medium

Multiple unrelated companies use the Brightside name — confirm you're on.

Pros and cons

Pros

  • Offers therapy and psychiatry, including persistent depressive disorder care
  • Insurance accepted; HSA/FSA eligibility discussed
  • Expanding care to Medicare and Medicaid populations
  • Financial assistance offered, per independent reviewers
  • Mobile app available for Android

Cons

  • Users report incorrect copay charges
  • Pricing cited as a con in user reviews
  • BBB complaints on file
  • Complaints noted by independent therapy reviewers

Sources & method

Analyzed 10/04/2026 - 11 sources - No known vulnerabilities found in the sources reviewed.

official x1review x8security x1news x1

Key stats

  • Value for money: 3/5

    Rating

  • Not disclosed

    Starting price

  • 11

    Sources

  • Analyzed

  • Value for money: 3/5. Insurance accepted; pricing and billing complaints persist
  • Ease of use. No usable evidence in sources
  • Feature depth: 4/5. Therapy plus psychiatry, specialty PDD care, app
  • Support quality: 2/5. Billing errors and complaints documented
  • Security posture: 3/5. Breach-notification policy; no public incidents found
  • $33M Series C funding Raised March 2024
  • 15 Complaintsboard reviews Mostly patient complaints
  • Private IPO status Pre-IPO shares via EquityZen

Pricing

Not disclosed

Security

No known vulnerabilities found in the sources reviewed.

Full analysis

Based on ~18 public sources; several unrelated 'Brightside' companies (insurer, cybersecurity, finance) were excluded from analysis.

Legit telepsychiatry with insurance support, but billing and pricing complaints recur — good for meds, not for therapy.

Methodology

Based on ~18 public sources; several unrelated 'Brightside' companies (insurer, cybersecurity, finance) were excluded from analysis.

Sources

  1. review
  2. review
  3. review
  4. review
  5. review
  6. review
  7. review
  8. news
  9. review
  10. official
  11. security

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.